EUVIMED · CrossrefZeitschrift
Pharmacology & Therapeutics
ISSN 0163-7258 · Elsevier BV
Neueste Artikel
Prospects for adiponectin-based therapeutics in myocardial ischemia reperfusion injury
Navigating the landscape of stem cell therapeutics: Overcoming translational hurdles via emerging technologies and regulatory frontiers
Pharmacological targeting of ANO1/TMEM16A in cancer: from channel inhibition to protein downregulation
Prospects for treatment of cerebral ischemic stroke with Hydroxysafflower Yellow A
Embarking on a new era in high-risk biochemical recurrent prostate cancer: redefining early systemic intervention
Targeting glycine transporter type 1 (GlyT1) in epilepsy: Pathophysiological rationale and therapeutic perspectives
Clusterin as a therapeutic agent: Bridging the gap in brain and eye research
Targeting metabolic reprogramming in cancer: Past, present, and future
Antimicrobial photodynamic therapy across ESKAPE pathogens: Efficacy, limitations, and a pathogen-adapted framework toward clinical translation
B-cell precursor acute lymphoblastic leukaemia: origins, classification, and therapeutic advances
Targeting depression: Pharmacological mechanisms and therapeutic targets
Apolipoprotein E in spinal cord injury: mechanisms of lipid dysregulation, neuroinflammation, and opportunities for repair
Cell death-induced chronic inflammation as a therapeutic target for metabolic dysfunction-associated steatohepatitis
Neuroregulation as a modulatory force in immune checkpoint inhibitor resistance: mechanistic neuro-immune crosstalk informing biomarker-led diagnosis and targetable therapeutic sensitization
Galectin-3 and its inhibitors: Overview and perspectives
Drug resistance in cancer: Emerging mechanisms, translational barriers, and pharmacological strategies
The rhythm of pressure: Circadian disruption and chronotherapy
The regulatory and therapeutic potential of transposable elements in cancer and inflammatory diseases
Targeting KCC2 and NKCC1 for spinal motor dysfunction: pharmacology, therapeutic opportunities, and translational roadmap
Mitochondrial dysfunction in Alzheimer’s disease: mechanisms, pathogenic interplay, and therapeutic opportunities
Sinoatrial node dysfunction: molecular mechanisms, arrhythmogenesis, and translational pathways toward precision therapy
Nucleic acid therapeutics for reinvigorating p53 function in glioblastoma: concepts, limitations and recent advances
Editorial Board
Mechanisms of ‘metabolizeaccretion’ and therapeutic targets in influenza infection
Phytocannabinoids in neurologic, neuropsychiatric, inflammatory, pain, cardiometabolic, hepatic, renal, and neoplastic disorders: Pharmacology, clinical evidence, and translational perspectives
Mitochondrial dynamics and metabolic regulation in cellular inflammation: From mechanisms to precision therapeutics
Disarming the “Neural Hijack”: Repurposing neuroactive drugs for cancer therapy
The CircRNA/miRNA axis in breast cancer: From molecular mechanisms to clinical translation
Novel therapeutic targets and drug discovery strategies in chronic obstructive pulmonary disease
Advances in iron-based chemodynamic anti-cancer therapy
Jahrgänge
2027 · 32026 · 852025 · 1152024 · 1082023 · 1712022 · 2342021 · 1732020 · 1652019 · 1612018 · 1722017 · 1422016 · 1312015 · 1192014 · 1082013 · 1052012 · 1092011 · 1032010 · 1042009 · 1042008 · 942007 · 1152006 · 1352005 · 1022004 · 822003 · 892002 · 812001 · 652000 · 871999 · 791998 · 471997 · 751996 · 601995 · 741994 · 681993 · 781992 · 571991 · 881990 · 961989 · 1101988 · 115
EUVIMED